# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013945
Filing Date
2023-05-11
Accepted
2023-05-11 16:10:50
Documents
96
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | nby20230331_10q.htm iXBRL | 10-Q | 1353167
2 | EXHIBIT 31.1 | ex_512611.htm | EX-31.1 | 8170
3 | EXHIBIT 31.2 | ex_512612.htm | EX-31.2 | 8476
4 | EXHIBIT 32.1 | ex_512613.htm | EX-32.1 | 4147
5 | EXHIBIT 32.2 | ex_512614.htm | EX-32.2 | 4192
| Complete submission text file | 0001437749-23-013945.txt |  | 8639470

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20230331.xsd | EX-101.SCH | 94399
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20230331_cal.xml | EX-101.CAL | 45052
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20230331_def.xml | EX-101.DEF | 590223
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20230331_lab.xml | EX-101.LAB | 464301
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20230331_pre.xml | EX-101.PRE | 622862
90 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20230331_10q_htm.xml | XML | 1565037

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 23911100
SIC: 2834 Pharmaceutical Preparations